These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24567721)

  • 1. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain.
    Levin R; Peres FF; Almeida V; Calzavara MB; Zuardi AW; Hallak JE; Crippa JA; Abílio VC
    Front Pharmacol; 2014; 5():10. PubMed ID: 24567721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit.
    Almeida V; Levin R; Peres FF; Suiama MA; Vendramini AM; Santos CM; Silva ND; Zuardi AW; Hallak JEC; Crippa JA; Abílio VC
    Neuropharmacology; 2019 Sep; 155():44-53. PubMed ID: 31103618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain.
    Almeida V; Peres FF; Levin R; Suiama MA; Calzavara MB; Zuardi AW; Hallak JE; Crippa JA; Abílio VC
    Schizophr Res; 2014 Mar; 153(1-3):150-9. PubMed ID: 24556469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia.
    Levin R; Almeida V; Peres FF; Calzavara MB; da Silva ND; Suiama MA; Niigaki ST; Zuardi AW; Hallak JE; Crippa JA; Abílio VC
    Curr Pharm Des; 2012; 18(32):4960-5. PubMed ID: 22716146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy.
    Peres FF; Levin R; Almeida V; Zuardi AW; Hallak JE; Crippa JA; Abilio VC
    Front Pharmacol; 2016; 7():303. PubMed ID: 27667973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine.
    Levin R; Calzavara MB; Santos CM; Medrano WA; Niigaki ST; Abílio VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1748-52. PubMed ID: 21693159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combined 5-HT
    Marques AM; Macena MV; Cardoso AR; Hammes CSO; Pinheiro FML; Castro NG; Neves GA
    Psychopharmacology (Berl); 2020 Jun; 237(6):1643-1655. PubMed ID: 32095916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.
    Ballmaier M; Bortolato M; Rizzetti C; Zoli M; Gessa G; Heinz A; Spano P
    Neuropsychopharmacology; 2007 Oct; 32(10):2098-107. PubMed ID: 17299506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young spontaneously hypertensive rats (SHRs) display prodromal schizophrenia-like behavioral abnormalities.
    Niigaki ST; Peres FF; Ferreira L; Libanio T; Gouvea DA; Levin R; Almeida V; Silva ND; Diana MC; Suiama MA; Calzavara MB; Abilio VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():169-176. PubMed ID: 30500412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol effects on prepulse inhibition in nonhuman primates.
    Saletti PG; Tomaz C
    Rev Neurosci; 2018 Dec; 30(1):95-105. PubMed ID: 29794254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
    Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
    Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor.
    Fernandez-Espejo E; Galan-Rodriguez B
    Psychopharmacology (Berl); 2004 Sep; 175(2):220-4. PubMed ID: 15088080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.
    Brzózka MM; Fischer A; Falkai P; Havemann-Reinecke U
    Behav Brain Res; 2011 Apr; 218(2):280-7. PubMed ID: 21070814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine.
    Pedrazzi JF; Issy AC; Gomes FV; Guimarães FS; Del-Bel EA
    Psychopharmacology (Berl); 2015 Aug; 232(16):3057-65. PubMed ID: 25943166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
    Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
    Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?
    Calzavara MB; Medrano WA; Levin R; Kameda SR; Andersen ML; Tufik S; Silva RH; Frussa-Filho R; Abílio VC
    Schizophr Bull; 2009 Jul; 35(4):748-59. PubMed ID: 18281713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model.
    Santos CM; Peres FF; Diana MC; Justi V; Suiama MA; Santana MG; Abílio VC
    Schizophr Res; 2016 Oct; 176(2-3):552-559. PubMed ID: 27338757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.
    Osborne AL; Solowij N; Babic I; Lum JS; Newell KA; Huang XF; Weston-Green K
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109666. PubMed ID: 31202911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
    Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
    Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats.
    Wheal AJ; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 2007 Nov; 152(5):717-24. PubMed ID: 17700721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.